Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
G | 0.700 | GeneticVariation | CLINVAR | Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens. | 24370118 | 2014 |
|||
|
C | 0.700 | CausalMutation | CLINVAR | Characteristics of lung cancers harboring NRAS mutations. | 23515407 | 2013 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | Characteristics of lung cancers harboring NRAS mutations. | 23515407 | 2013 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | Characteristics of lung cancers harboring NRAS mutations. | 23515407 | 2013 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Characteristics of lung cancers harboring NRAS mutations. | 23515407 | 2013 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Characteristics of lung cancers harboring NRAS mutations. | 23515407 | 2013 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | Characteristics of lung cancers harboring NRAS mutations. | 23515407 | 2013 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Characteristics of lung cancers harboring NRAS mutations. | 23515407 | 2013 |
|||
|
C | 0.700 | CausalMutation | CLINVAR | Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. | 22773810 | 2012 |
|||
|
C | 0.700 | CausalMutation | CLINVAR | Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells. | 19880792 | 2010 |
|||
|
C | 0.700 | CausalMutation | CLINVAR | Somatic mutations affect key pathways in lung adenocarcinoma. | 18948947 | 2008 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | Somatic mutations affect key pathways in lung adenocarcinoma. | 18948947 | 2008 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | Somatic mutations affect key pathways in lung adenocarcinoma. | 18948947 | 2008 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Somatic mutations affect key pathways in lung adenocarcinoma. | 18948947 | 2008 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | Somatic mutations affect key pathways in lung adenocarcinoma. | 18948947 | 2008 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. | 18794081 | 2008 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Somatic mutations affect key pathways in lung adenocarcinoma. | 18948947 | 2008 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Somatic mutations affect key pathways in lung adenocarcinoma. | 18948947 | 2008 |
|||
|
C | 0.700 | CausalMutation | CLINVAR | BRAF mutations in papillary carcinomas of the thyroid. | 14508525 | 2003 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |
|||
|
C | 0.700 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |
|||
|
T | 0.700 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |
|||
|
A | 0.700 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |